| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CGP-082996 | GDSC1000 | pan-cancer | AAC | -0.053 | 0.3 |
| mRNA | I-BET151 | CTRPv2 | pan-cancer | AAC | 0.032 | 0.3 |
| mRNA | CMK | GDSC1000 | pan-cancer | AAC | -0.054 | 0.3 |
| mRNA | Teniposide | CTRPv2 | pan-cancer | AAC | -0.04 | 0.3 |
| mRNA | procarbazine | CTRPv2 | pan-cancer | AAC | 0.04 | 0.3 |
| mRNA | Parthenolide | CTRPv2 | pan-cancer | AAC | -0.039 | 0.3 |
| mRNA | ZM-447439 | GDSC1000 | pan-cancer | AAC | -0.036 | 0.3 |
| mRNA | Compound 23 citrate | CTRPv2 | pan-cancer | AAC | -0.034 | 0.3 |
| mRNA | BRD-K37390332 | CTRPv2 | pan-cancer | AAC | 0.04 | 0.3 |
| mRNA | SGX-523 | CTRPv2 | pan-cancer | AAC | -0.038 | 0.3 |